



















The	 Mycobacterial	 load	 assay	 (MBLA)	 is	 a	 culture-free	 biomarker	 that	 aims	 at	
providing	 rapid	 quantification	 of	 viable	 Mycobacterium	 tuberculosis	 in	 patient	
sputum.	 The	 assay	 monitors	 the	 molecular	 load	 of	M.	 tuberculosis	 (Mtb)	 cells	 in	
sputum	 samples	 providing	 accurate	 information	 on	 bacterial	 response	 (decline)	 to	
antimicrobial	 treatment.	 The	 bacterial	 load	 is	 determined	 by	 detection	 and	
quantification	of	Mtb	16S	ribosomal	RNA	(16S	rRNA)	using	reverse	transcriptase	real-
time	quantitative	polymerase	chain	reaction	(RT-qPCR).	The	16S	rRNA	is	a	structural	
RNA	 occurring	 in	multiple	 copies	 in	 a	 bacterial	 cell	 and	 its	 half	 life	 and	 stability	 is	
considerably	greater	in	comparison	to	mRNA.	This	makes	16S	rRNA	a	suitable	marker	
for	 the	detection	and	quantification	of	viable	bacterial	 load	as	 it	 is	associated	with	
intact	viable	cells.	When	Mtb	cells	are	killed	by	anti-TB	therapy,	the	amount	of	16S	




directly	 quantifies	 bacterial	 load	 in	 sputum	 while	 MGIT	 gives	 an	 indirect	
measurement	 based	 on	 time	 to	 detection	 (time	 taken	 for	 the	 sample	 to	 flag	
positive).	 The	 higher	 the	 bacterial	 load	 in	 patient	 sputum	 the	 shorter	 the	 time	 to	
positivity	 (TTP)	 on	 MGIT.	 In	 comparison	 to	 MGIT,	 MBLA	 is	 faster,	 insensitive	 to	













Using	 this	 methodology	 it	 is	 possible	 to	 follow	 the	 decline	 in	 bacterial	 load	 of	
patients	being	treated	for	tuberculosis.		Since	this	is	a	molecular	method,	the	results	

















8. Refrigerated	 micro-centrifuge	 (with	 sealed	 removable	 rotor,	 for	 1.5	 ml	
Microcentrifuge	 tubes	 and	 2	 ml	 homogenization	 tubes),	 e.g.	 Fresco	 21,	
Heraeus	
9. Homogenizer,	 e.g.	 Fastprep,	MP	 Biomedical	 (setting	 P60,	 40	 s)	 or	 Precellys	
24,	PeqLab	(setting	6000	rpm,	40	s)	
10. Thermomixer,	 with	 thermoblock	 for	 1.5	ml	microtubes,	 e.g.	 BLD-455-010C,	
Microcentrifuge	tube	















9. Racks	 for	 1.5	 ml	 and	 2	 ml	 microtubes	 and	 for	 15ml	 and	 50	 ml	 Falcon	
tubes,	chemical-resistant	and	autoclavable	
10. Sterile	disposable	universal	tubes	and	15	ml	and	50	ml	Falcon	tubes	
11. Sterile	RNA-ase-free	microtubes	 (1.5	ml	Microcentrifuge	 tubes),	 suitable	
for	storing	at	-80°C	
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3. Molecular	 grade	 water,	 DNase	 and	 RNA-ase	 free,	 e.g.,	 13138533,	 Fisher	
Scientific	
4. Solution	to	remove	RNases	from	work	surfaces	and	equipment,	e.g.		RNA-ase	

































10μL	 	 10μL	 	
Mtb16S	 F+	 R		
primer	mix	
0.4μL	 	 0.4μL	 	
Mtb16S-FAM	
probe	
0.2μL	 	 0.2μL	 	
Mm	 IC	 tmRNA	 F+R	
primer	mix	
0.4μL	 	 0.4μL	 	
Mm	 IC	 tmRNA	
probe	
0.2μL	 	 0.2μL	 	
RT	enzyme	 0.2μL	 	 -------	 	
RNA-ase	free	water	 4.6μL	 	 4.8μL	 	
Total	volume	 16µl	 	 16μL	 	
	
	
16. RT+,	 reaction	 containing	 reverse	 transcriptase;	 RT-,	 reaction	 without	
reverse	 transcriptase;	 V,	 volume;	 F+R,	 forward	 and	 reverse	 primer	
mixture	
Name Sequence
Mtb 16s Forward GTGATCTGCCCTGCACTTC
Mtb 16s Reverse ATCCCACACCGCTAAAGCG
IC MMtmRNA F CGTCATCCTGGCTAGTTC
IC MMtmRNA R CTACGGCATTCCCTCAAG
Mtb 16s probe FAM-AGGACCACGGGATGCATGTCTTGT-BHQ1
IC MMtmRNA  probe HEX-AGT CCG CTA TGT CTC TGC TCG-BHQ1
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17. Prepare	 artificial	 sputum	 with	 400mL	 distilled	 water,	 2.5g	 pig	 stomach	
mucin	 (Sigma),	 3.0g	 diethylene	 triamine	 pentacetic	 acid	 (DTPA),	 2.5g	
sodium	chloride,	1.1g	potassium	chloride,	125mg	each	of	the	20	essential	












	Both	 patient	 sputum	 specimens	 and	 BCG	 positive	 controls	 in	 artificial	










Aliquot	 the	 mix	 by	 200	 µl	 into	 1.5ml	 RNA-ase	 free	 Micro-centrifuge	 tube	

















b. Prepare	 20	 µM	 probe	 solution,	 label	 RNA-ase-free	 1.5	 ml	 Micro-










3) Prepare	 corresponding	 number	 of	 homogenization	 (containing	 glass	 micro	
beads)	tubes	and	label	them	according	to	samples’	IDs	and	controls’	numbers	
both	on	 the	 tube	and	on	 the	 lid.	 If	 you	number	 samples	 then	make	 record	
with	full	reference	of	the	patient	ID	and	corresponding	tube	numbers.		
4) Make	sure	all	 tubes	with	samples	and	controls	are	properly	 labelled	(name,	
control	concentration	or	dilution,	and	date).		
5) Add	100	μl	internal	control	suspension	into	each	sample	and	standard	tube.	
Pipette	directly	 into	 the	 liquid	and	not	on	 the	side	of	 the	plastic	 tube.	 	Mix	
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13) After	 homogenization,	 centrifuge	 the	 tubes	 for	 5	min	 at	 12,000	g	 at	 room	
temperature.	
14) Leave	the	tube	to	stand	for	5	minutes	following	centrifugation.	
15) Label	 fresh	 1.5	ml	 screw	 cap	 tubes	 (RNA-ase	 free)	 with	 the	 corresponding	
numbers.	
16) Add	300	μl	chloroform	into	each	clean	tube	
17) From	 the	 homogenization	 tubes,	 carefully	 transfer	 the	whole	 liquid	 part	 to	






21) Label	 new	 1.5	 ml	 micro-centrifuge	 tube	 tubes	 with	 the	 corresponding	
numbers	




25) Transfer	 the	 tubes	containing	 samples	 to	 the	 -20°C	 freezer	overnight	 (or	 to	








31) Discard	 the	 supernatant	 using	 a	 Pasteur	 pipette	 with	 fine	 tip.	 Use	 a	 new	
pipette	for	every	sample.	
32) Dry	the	RNA	at	50°C	in	a	heat	block	(approximately	20-30	min)	








1) When	 using	 Turbo	 DNA-free	 kit	 (Ambion	 AM1907),	 prepare	 a	 master-mix	
containing	Turbo	DNase	I	10x	buffer	and	DNase	I	enzyme	for	the	number	of	
samples	 (plus	 two	 extra	 to	 avoid	 pipetting	 errors).	 Per	 sample,	 add	 10	 μl	
buffer	 and	 1	 μl	 DNase	 enzyme	 to	 each	 sample.	 For	 example,	 a	 10	 sample	
	 10	
master	mix	would	 contain	 120	 μl	 10x	 buffer	 and	 12	 μl	 of	 DNase	 enzymes.	
(Note	13	and	14)		
2) Add	11µl	 of	DNA-ase-buffer	master-mix	 to	each	 sample	 (Note	 15).	 	Mix	by	
vortexing	and	then	spin	briefly	(5–10	s	at	13000	g)	to	bring	everything	to	the	








the	 finish	 of	 DNase	 incubation	 and	 keep	 in	 the	 fridge.	 Re-suspend	 by	
vortexing.		
7) Add	10	μl	of	DNase	inactivation	reagent	into	each	RNA	extract	





















































5. Instruct	 the	 Robot	 to	 add	 16	 μl	master	mix	 and	 4	 μl	 sample	 RNA	 into	 the	
reaction	tubes	(0.2	ml	thin-walled	PCR	tubes	for	36-well	rotor	or	4-strip	cap	
tubes	for	72-well	rotor).			
6. Each	 sample	 and	 control	 should	 be	 run	 in	 duplicate	 in	 RT-qPCR	 (RT+,	








1) When	 the	 reaction	 tubes	 are	 in	 the	 appropriate	 rotor,	 lock	 them	 in	 the	

















g. If	 reaction	 conditions	 are	 correct	 press	 the	 “Start	 Run”	 button.	 You	








and	 treatment	 monitoring.	 Amplification	 data	 for	 Mtb	 samples	 and	 BCG	 and	 IC	













1. If	 no	 amplification	 is	 detected	 for	 the	 internal	 control	 (Yellow	 channel),	
ascertain	 that	 the	 internal	control	was	added	 into	 the	samples	by	 revisiting	
Target (Mtb/BCG) IC Result 
+ + + 
























in	 sputum	 samples	 and	 can	 provide	 accurate	 information	 on	 bacterial	 response	
(decline)	to	antimicrobial	treatment.	The	concentration	of	TB	is	calculated	from	16S	
rRNA	 present	 in	 the	 sample.	 	 The	 principle	 of	 the	 MBL	 assay	 is	 absolute	
quantification	based	on	a	standard	curve	consisting	of	a	set	of	RNA	templates	with	
known	 concentration.	 The	 standard	 curve	 is	 used	 to	 calculate	 the	 Mtb		
concentration	of	an	unknown	clinical	sample.			
A	 separate	 standard	 curve	 is	 used	 for	Mtb	 quantification	 and	 a	 separate	 curve	 is	
used	 for	 the	 quantification	 of	mycobacterial	 internal	 control	 (IC).	 Standard	 curves	





1. Use	RNA	extracted	 from	 standard	material	 as	 detailed	 (Notes	 2	 and	3),	 i.e.	M.	
bovis	BCG	culture	and	MM-IC	cell	suspensions	with	estimated	concentrations	of	
108	CFU/ml	or	greater.	Work	on	ice.	
2. Prepare	7	1.5	ml	RNase-free	 tubes	 and	 label	 them	with	 appropriate	name	and	




3. Set	up	 the	RT-qPCR	mastermixes	as	outlined	above	 in	chapter	“RT-qPCR”	using	
appropriate	primers	and	probes	combinations.	
4. The	 standards	 are	 amplified	 in	 duplicates	 (along	 with	 the	 samples	 or	 on	 their	
own).	Use	4	µl	of	RNA	dilution	and	16	µl	of	mastermix	per	reaction.		
5. For	 each	 type	 of	 RotorGene	Q	 rotor,	 i.e.	 36-well	 or	 72-well,	 create	 a	 separate	
standard	curve.	Note:	the	reaction	volume,	type	of	reaction	tubes	and	rotor	can	
influence	 the	 PCR	 performance	 and	 fluorescence	 reading,	 and	 hence,	 cause	
minor	variations	in	fluorescence	signal	and	the	resulting	CT	values.	
6. In	RotorGene	Q	software,	 label	 the	standards	 in	sample	sheet	and	assign	 them	




A	standard	curve	can	be	prepared	 in	a	separate	run	 for	 the	use	with	RotorGene	Q	
and	 it	 can	 be	 further	 incorporated	 in	 data	 analysis	 of	 samples	 with	 unknown	
bacterial	load.	
1. Analyze	 the	 amplification	 curves	 in	 appropriate	 fluorescence	 channel,	 i.e.	





IC	 channels.	 Note:	 the	 threshold	 can	 be	 set	 to	 0.02	 if	 this	 improves	 the	
efficiency	of	the	reaction.	
3. Go	 to	 “Analysis”	 option	 and	 select	 the	 channel	 and	 sample	 sheet	 you	 are	
going	to	analyze.	
4. Click	on	“Slope	correct”	in	order	to	minimize	the	fluorescence	fluctuations.	
5. When	 standards	 and	 their	 respective	 concentrations	 are	 assigned	 in	 the	


















8.	 Very	high	or	 too	 low	RNA	 concentrations	 in	 the	RT-PCR	 reaction	 can	 cause	
fluctuations	in	reverse	transcription	and	subsequent	PCR	efficiency.	These	result	







MBLA	 is	 an	 assay	 for	 absolute	 quantification	 of	 an	 unknown	 target.	 Every	 RNA	






2. When	 amplification	 of	 a	 series	 of	 unknown	 samples	 to	 be	 analyzed	 is	






6. Click	 on	 the	 amplification	 curves	 window.	 An	 option	 for	 standard	 curve	
import	will	appear	in	the	right	hand	side	of	the	screen.	





BCG	 controls,	 which	 you	 had	 assigned	 as	 standards.	 Select	 adjust	 and	
continue.	
9. The	 software	 now	 automatically	 populates	 the	 standard	 curve	 into	 your	
current	run	and	calculates	the	concentrations	of	the	unknown	samples.	The	
samples	 will	 appear	 plotted	 on	 the	 standard	 curve	 according	 to	 their	 CT	






















Work	 in	 the	 fume	 cabinet	 wearing	 lab	 coat,	 gloves	 and	 safety	 goggles.	 Carefully	
weigh	and	 transfer	200	g	GTC	powder	 into	 the	500	ml	plastic	 container.	 	Measure	













period	 of	 time.	 This	 allows	 sample	 batching	 and	 simplifies	 sample	 processing	 for	





culture	 is	 prepared	 by	 inoculating	 BCG	 into	 7H9	medium	 (with	 10%	OADC	or	 ADC	
growth	supplement)	and	 incubating	 it	at	37oC	 for	up	to	 three	weeks.	The	bacterial	






the	BCG	culture	 into	artificial	 sputum	to	a	concentration	of	103	 to	104	CFU/ml	and	






The	 Internal	 (extraction)	 control	 is	 prepared	 from	 a	 log	 phase	 of	Mycobacterium	









Use	 a	 different	 fraction	 of	 the	 same	 M.	 marinum	 culture	 to	 determine	 its	
concentration	 (CFU/ml)	 by	 inoculating	 7H10	 agar	 and	 incubating	 at	 30oC	 for	 3	 –	 5	
days.	 Thaw	 the	 frozen	 pellets	 at	 room	 temperature	 and	 re-suspend	 in	 GTC	
supplemented	with	1%	b-mercaptoethanol	solution	to	105	CFU/ml.	Store	at	-80oC	for	
long	 term	use.	At	 the	 time	of	 sample	RNA	extraction,	 spike	 each	 sample	 and	BCG	








Keep	 the	 water	 sterile	 at	 room	 temperature.	 To	 prevent	 any	 contamination,	 it	 is	














the	 organisms	 are	 confirmed	 to	 be	 killed.	 The	 lysis	 kills	Mtb,	 and	 the	 rest	 of	 the	
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